Trademarkia Logo

Australia

AU$
EXGLENTRA
Cancelled: Cancelled at the request of IB

Last updated on 15 Feb 2023

Owner Info

Calithera Biosciences, Inc.

343 Oyster Point Blvd., Suite 200

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

2061809 filed on 13 Dec 2019

Correspondent

Jenevieve Maerker Foley Hoag LLP

155 Seaport Blvd.,

Boston MA 02210-2600,

UNITED STATES OF AMERICA

EXGLENTRA

Classification Information


Class [005]
Pharmaceuticals for human use; pharmaceuticals for the treatment of cancer, tumors, and oncological diseases and disorders.

Mark Details


Serial Number

2061809

Registered On

13 Dec 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

28 Jun 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
15th Feb 2023Status change to Voided
30th Jun 2020International Registration in Australia Protected correspondence sent
29th Jun 2020IP Right Registration Published
29th Jun 2020Status change to Registered/Protected
21st Apr 2020Application Accepted correspondence sent
20th Apr 2020IP Right has been Examined
20th Apr 2020IP Right Acceptance Published
20th Apr 2020Status change to Accepted
9th Jan 2020Awaiting examination
9th Jan 2020Examination expedited